MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TN-02-0083774
Tricept Pharmaceuticals Private Limited
Tricept Pharmaceuticals Private Limited - pharma in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2022
₹16.44 Lakh
▼ 97% YoY
Net profit · FY 2022
₹47,955
Net margin 2.9%
EBITDA · FY 2022
₹18.18 Lakh
EBITDA margin 110.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.54 Cr
Satisfied ₹89 Lakh
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
About Tricept Pharmaceuticals Private Limited
Data last updated:
Tricept Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U51909TN2017PTC118587. Its GSTIN is 33AACCU1435G1ZQ (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It was formerly known as Uday Medisales Private Limited. It is led by directors Ganesan Magesh and Kamal Chand.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at Kuppa Swamy Complex 34/6 Raja Bather Street T.Nagar, Chennai, Tamil Nadu, India – 600017.
As per the financials filed for FY 2022, the company reported a revenue of ₹16.44 Lakh, a decline of 97% compared to the previous year. For the same year it recorded a net profit of ₹47,955 (net margin 2.9%) and EBITDA of ₹18.18 Lakh (EBITDA margin 110.6%). Revenue has declined at a compounded annual rate (CAGR) of 67% over three years.
As per MCA filings, the company has open charges of ₹1.54 Cr and satisfied charges of ₹89 Lakh on record.
Tricept Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0083774). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U51909TN2017PTC118587
Registration Number 118587
Incorporation Date 13 September 2017
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2022
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0083774
Key People
Ganesan Magesh Director Kamal Chand Director Recognitions & Rankings of Tricept Pharmaceuticals
Contact details
Tricept Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKuppa Swamy Complex 34/6 Raja Bather Street T.Nagar, Chennai, Tamil Nadu, India – 600017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Tricept Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Tricept Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Tricept Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Tricept Pharmaceuticals Private Limited, buy the company report.
Financials of Tricept Pharmaceuticals Private Limited
FY 2022 filings availableTricept Pharmaceuticals Private Limited reported revenue of ₹16.44 Lakh (down 97% YoY) for FY 2022.
Revenue · FY 2022
₹16.44 Lakh ▼ 97%
Net profit · FY 2022
₹47,955 margin 2.9%
EBITDA · FY 2022
₹18.18 Lakh margin 110.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 97%
3 years · compounded
▼ 67%
EBITDA CAGR growth
1 year
▲ 157%
3 years · compounded
▲ 27%
Revenue has declined at a compounded annual rate (CAGR) of 67% over three years, including a 97% fall in the latest year. EBITDA rose 157% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹16.44 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.18 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹47,955 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 110.6% | ||||
| Net Profit Margin | 2.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tricept Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tricept Pharmaceuticals Private Limited
Tricept Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganesan Magesh Also directs: Life Synergy India Private Limited | Director | 15 Mar 2019 | 7 Years 7 Months | Current |
| Kamal Chand Also directs: Avixaa Aesthetiq Private Limited, Tricept Life Sciences Private Limited, National Medicines Private Limited and 1 more | Director | 14 Mar 2022 | 4 Years 7 Months | Current |
Peer comparison
Tricept Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mylyn Care Private Limited | ₹16.45 Lakh (FY 2023) | 52.0% | Mumbai, Maharashtra, India | |||
| Helax Probic Private Limited | ₹16.44 Lakh (FY 2024) | 141.0% | Delhi, India | |||
| Tricept Pharmaceuticals Private Limitedthis company | ₹16.44 Lakh (FY 2022) | ₹47,955 | 2.9% | -97.0% | Chennai, Tamil Nadu, India | |
| Manandi Pharmaceuticals Private Limited | ₹16.43 Lakh (FY 2025) | -32.0% | Muzaffarpur, Bihar, India | |||
| Synergy Formulation Private Limited | ₹16.43 Lakh (FY 2025) | -52.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Tricept Pharmaceuticals Private Limited, buy the company report.
Shareholding
The shareholding of Tricept Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Tricept Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.54 Cr
Satisfied charges
₹89 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Nov 2020 | 100411816 | Others | ₹1.54 Cr | Open | |
| 04 Jun 2020 | 100345853 | Indian Bank | ₹12 Lakh | Satisfied | |
| 09 Apr 2020 | 100345855 | Indian Bank | ₹7 Lakh | Satisfied | |
| 05 Aug 2019 | 100291506 | Indian Bank | ₹70 Lakh | Satisfied |
To see the full charge records of Tricept Pharmaceuticals Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Tricept Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tricept Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Tricept Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCU1435G1ZQ | Tamil Nadu | Active | 06 Oct 2017 |
To see the full GST registrations and return filing status of Tricept Pharmaceuticals Private Limited, buy the company report.
Recent activity
Tricept Pharmaceuticals Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Kamal Chand ceased to be Additional Director on 30 Sep 2022.
AGM
Tricept Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Ceased
Kamal Chand ceased to be Additional Director.
Filing
Tricept Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Chennai.
Ceased
Babithajain ceased to be Director.
Appointed
Kamal Chand was appointed as Director.
Charges
A charge registered on 04 Jun 2020 via Charge ID 100345853 with Indian Bank was fully satisfied on 20 Jan 2021.
Charges
A charge registered on 09 Apr 2020 via Charge ID 100345855 with Indian Bank was fully satisfied on 20 Jan 2021.
Charges
A charge registered on 05 Aug 2019 via Charge ID 100291506 with Indian Bank was fully satisfied on 20 Jan 2021.
Charges
A charge with Others amounted to Rs. 154.00 Lakh with Charge ID 100411816 was registered on 23 Nov 2020.
Charges
A charge with Indian Bank amounted to Rs. 12.00 Lakh with Charge ID 100345853 was registered on 04 Jun 2020.
Charges
A charge with Indian Bank amounted to Rs. 7.00 Lakh with Charge ID 100345855 was registered on 09 Apr 2020.
Ceased
Saurab Jain ceased to be Director.
3 earlier events are in the company report.
Frequently asked questions
Tricept Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 September 2017 (9+ years old) and is registered under CIN U51909TN2017PTC118587.
Tricept Pharmaceuticals has 2 current directors:
- Ganesan Magesh - Director
- Kamal Chand - Director
The latest financial statements of Tricept Pharmaceuticals on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Tricept Pharmaceuticals is 33AACCU1435G1ZQ, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Tricept Pharmaceuticals is U51909TN2017PTC118587. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tricept Pharmaceuticals was incorporated on 13 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Tricept Pharmaceuticals by revenue are Mylyn Care Private Limited, Helax Probic Private Limited, Manandi Pharmaceuticals Private Limited, Synergy Formulation Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kamal Chand ceased to be Additional Director on 30 Sep 2022. Babithajain ceased to be Director on 15 Mar 2022. Kamal Chand was appointed as Director on 14 Mar 2022. Tricept Pharmaceuticals has 5 board changes on record in total.
Yes, Tricept Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0083774).
The registered office of Tricept Pharmaceuticals is at Kuppa Swamy Complex 346 Raja Bather Street T.Nagar, Chennai, Tamil Nadu, India – 600017.
Tricept Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.